Need immediate assistance? Call 1-518-730-0559 (Us-Canada Toll Free) or Contact Us

 

Oxytocic Pharmaceuticals Market: Labour Induction Segment Expected to Register Moderate Y-o-Y Growth Throughout the Forecast Period: Global Industry Analysis & Opportunity Assessment, 2016-2026

Table of Content

Table Of Content

1. Executive Summary

2. Market Introduction
2.1. Market Definition
2.2. Market Taxonomy

3. Global Oxytocic Pharmaceuticals Market Analysis Scenario
3.1. Market Size (US$ Mn) and Forecast
3.1.1. Market Size and Y-o-Y Growth
3.1.2. Absolute $ Opportunity

4. Market Dynamics
4.1. Macro-economic Factors
4.2. Drivers
4.2.1. Supply Side
4.2.2. Demand Side
4.3. Restraints
4.4. Opportunity
4.5. Number of procedures by Indications per region (2015-2026)
4.6. Number of procedures by End User per region (2015-2026)
4.7. Number of cervical ripening procedures by region (2015)
4.8. Comparative drugs list other than Oxytocin

5. Global Oxytocic Pharmaceuticals Market Analysis and Forecasts, By Indication 
5.1. Introduction
5.2. Basis Point Share (BPS) Analysis By Indication Type
5.3. Y-o-Y Growth Projections By Indication Type
5.4. Market Value Forecast By Indication, 2016–2026
5.4.1. Abortion Induced Incomplete
5.4.2. Inevitable Abortion
5.4.3. Postpartum Hemorrhage
5.4.4. Labor Induction
5.4.5. Labor Arrest
5.5. Market Attractiveness By Indication 

6. Global Oxytocic Pharmaceuticals Market Analysis and Forecasts, By End User 
6.1. Introduction
6.2. Basis Point Share (BPS) Analysis By End User 
6.3. Y-o-Y Growth Projections By End User 
6.4. Market Value Forecast By End User, 2016–2026
6.4.1. Hospitals
6.4.2. Maternity Clinics
6.5. Market Attractiveness By End User 

7. Global Oxytocic Pharmaceuticals Market Analysis and Forecasts, By Route of Administration 
7.1. Introduction
7.2. Basis Point Share (BPS) Analysis By Route of Administration 
7.3. Y-o-Y Growth Projections By Route of Administration 
7.4. Market Value Forecast By Route of Administration, 2016–2026
7.4.1. Intravenous Infusion/Injection
7.4.2. Intramuscular Injection
7.5. Market Attractiveness By Route of Administration 

8. Global Oxytocic Pharmaceuticals Market Analysis and Forecasts, By Source of Origin 
8.1. Introduction
8.2. Basis Point Share (BPS) Analysis By Source of Origin 
8.3. Y-o-Y Growth Projections By Source of Origin 
8.4. Market Value Forecast By Source of Origin, 2016–2026
8.4.1. Synthetic Oxytocin Derivative
8.4.2. Natural Oxytocin (Animal Pituitary Extract)
8.5. Market Attractiveness By Source of Origin 

9. Global Oxytocic Pharmaceuticals Market Analysis and Forecasts, By Region
9.1. Basis Point Share (BPS) Analysis By Region
9.2. Y-o-Y Growth Projections By Region
9.3. Market Value Forecast By Region
9.3.1. North America 
9.3.2. Latin America 
9.3.3. Western Europe 
9.3.4. Eastern Europe 
9.3.5. China
9.3.6. Japan 
9.3.7. APEJC
9.3.8. MEA 
9.4. Market Attractiveness By Region

10. North America Oxytocic Pharmaceuticals Market Analysis and Forecast
10.1.Introduction
10.1.1. Basis Point Share (BPS) Analysis By Country
10.1.2. Y-o-Y Growth Projections By Country
10.2.Market Value Forecast By Indication, 2016–2026
10.2.1. Abortion Induced Incomplete
10.2.2. Inevitable Abortion
10.2.3. Postpartum Hemorrhage
10.2.4. Labor Induction
10.2.5. Labor Arrest
10.3.Market Value Forecast By End User, 2016–2026
10.3.1. Hospitals
10.3.2. Maternity Clinics
10.4.Market Value Forecast By Route of Administration, 2016–2026
10.4.1. Intravenous Infusion/Injection
10.4.2. Intramuscular Injection
10.5.Market Value Forecast By Source of Origin, 2016–2026
10.5.1. Synthetic Oxytocin Derivative
10.5.2. Natural Oxytocin (Animal Pituitary Extract)
10.6.Market Value Forecast By Country, 2016–2026
10.6.1. US
10.6.2. Canada
10.7.Market Attractiveness Analysis 
10.7.1. By Indication 
10.7.2. By End User 
10.7.3. By Route of Administration 
10.7.4. By Source of Origin 
10.7.5. By Country
10.8. Prominent Trends 

11. Latin America Oxytocic Pharmaceuticals Market Analysis and Forecast
11.1.Introduction
11.1.1. Basis Point Share (BPS) Analysis By Country
11.1.2. Y-o-Y Growth Projections By Country
11.2.Market Value Forecast By Indication, 2016–2026
11.2.1. Abortion Induced Incomplete
11.2.2. Inevitable Abortion
11.2.3. Postpartum Hemorrhage
11.2.4. Labor Induction
11.2.5. Labor Arrest
11.3.Market Value Forecast By End User, 2016–2026
11.3.1. Hospitals
11.3.2. Maternity Clinics
11.4.Market Value Forecast By Route of Administration, 2016–2026
11.4.1. Intravenous Infusion/Injection
11.4.2. Intramuscular Injection
11.5.Market Value Forecast By Source of Origin, 2016–2026
11.5.1. Synthetic Oxytocin Derivative
11.5.2. Natural Oxytocin (Animal Pituitary Extract)
11.6.Market Value Forecast By Country, 2016–2026
11.6.1. Brazil
11.6.2. Mexico
11.6.3. Rest of Latin America
11.7.Market Attractiveness Analysis 
11.7.1. By Indication 
11.7.2. By End User 
11.7.3. By Route of Administration 
11.7.4. By Source of Origin 
11.7.5. By Country
11.8. Prominent Trends 

12. Western Europe Oxytocic Pharmaceuticals Market Analysis and Forecast
12.1.Introduction
12.1.1. Basis Point Share (BPS) Analysis By Country
12.1.2. Y-o-Y Growth Projections By Country
12.2.Market Value Forecast By Indication, 2016–2026
12.2.1. Abortion Induced Incomplete
12.2.2. Inevitable Abortion
12.2.3. Postpartum Hemorrhage
12.2.4. Labor Induction
12.2.5. Labor Arrest
12.3.Market Value Forecast By End User, 2016–2026
12.3.1. Hospitals
12.3.2. Maternity Clinics
12.4.Market Value Forecast By Route of Administration, 2016–2026
12.4.1. Intravenous Infusion/Injection
12.4.2. Intramuscular Injection
12.5.Market Value Forecast By Source of Origin, 2016–2026
12.5.1. Synthetic Oxytocin Derivative
12.5.2. Natural Oxytocin (Animal Pituitary Extract)
12.6.Market Value Forecast By Country, 2016–2026
12.6.1. UK
12.6.2. France
12.6.3. Germany
12.6.4. Italy
12.6.5. Spain
12.6.6. Benelux
12.6.7. Rest of Western Europe
12.7.Market Attractiveness Analysis 
12.7.1. By Indication 
12.7.2. By End User 
12.7.3. By Route of Administration 
12.7.4. By Source of Origin 
12.7.5. By Country
12.8. Prominent Trends 

13. Eastern Europe Oxytocic Pharmaceuticals Market Analysis and Forecast
13.1.Introduction
13.1.1. Basis Point Share (BPS) Analysis By Country
13.1.2. Y-o-Y Growth Projections By Country
13.2.Market Value Forecast By Indication, 2016–2026
13.2.1. Abortion Induced Incomplete
13.2.2. Inevitable Abortion
13.2.3. Postpartum Hemorrhage
13.2.4. Labor Induction
13.2.5. Labor Arrest
13.3.Market Value Forecast By End User, 2016–2026
13.3.1. Hospitals
13.3.2. Maternity Clinics
13.4.Market Value Forecast By Route of Administration, 2016–2026
13.4.1. Intravenous Infusion/Injection
13.4.2. Intramuscular Injection
13.5.Market Value Forecast By Source of Origin, 2016–2026
13.5.1. Synthetic Oxytocin Derivative
13.5.2. Natural Oxytocin (Animal Pituitary Extract)
13.6.Market Value Forecast By Country, 2016–2026
13.6.1. Russia
13.6.2. Poland
13.6.3. Rest of Eastern Europe
13.7.Market Attractiveness Analysis 
13.7.1. By Indication 
13.7.2. By End User 
13.7.3. By Route of Administration 
13.7.4. By Source of Origin 
13.7.5. By Country
13.8. Prominent Trends 

14. APEJC Oxytocic Pharmaceuticals Market Analysis and Forecast
14.1.Introduction
14.1.1. Basis Point Share (BPS) Analysis By Country
14.1.2. Y-o-Y Growth Projections By Country
14.2.Market Value Forecast By Indication, 2016–2026
14.2.1. Abortion Induced Incomplete
14.2.2. Inevitable Abortion
14.2.3. Postpartum Hemorrhage
14.2.4. Labor Induction
14.2.5. Labor Arrest
14.3.Market Value Forecast By End User, 2016–2026
14.3.1. Hospitals
14.3.2. Maternity Clinics
14.4.Market Value Forecast By Route of Administration, 2016–2026
14.4.1. Intravenous Infusion/Injection
14.4.2. Intramuscular Injection
14.5.Market Value Forecast By Source of Origin, 2016–2026
14.5.1. Synthetic Oxytocin Derivative
14.5.2. Natural Oxytocin (Animal Pituitary Extract)
14.6.Market Value Forecast By Country, 2016–2026
14.6.1. India
14.6.2. Australia & New Zealand
14.6.3. ASEAN
14.6.4. Rest of APEJC
14.7.Market Attractiveness Analysis 
14.7.1. By Indication 
14.7.2. By End User 
14.7.3. By Route of Administration 
14.7.4. By Source of Origin 
14.7.5. By Country
14.8. Prominent Trends 

15. Japan Oxytocic Pharmaceuticals Market Analysis and Forecast
15.1.Introduction
15.1.1. Basis Point Share (BPS) Analysis By Country
15.1.2. Y-o-Y Growth Projections By Country
15.2.Market Value Forecast By Indication, 2016–2026
15.2.1. Abortion Induced Incomplete
15.2.2. Inevitable Abortion
15.2.3. Postpartum Hemorrhage
15.2.4. Labor Induction
15.2.5. Labor Arrest
15.3.Market Value Forecast By End User, 2016–2026
15.3.1. Hospitals
15.3.2. Maternity Clinics
15.4.Market Value Forecast By Route of Administration, 2016–2026
15.4.1. Intravenous Infusion/Injection
15.4.2. Intramuscular Injection
15.5.Market Value Forecast By Source of Origin, 2016–2026
15.5.1. Synthetic Oxytocin Derivative
15.5.2. Natural Oxytocin (Animal Pituitary Extract)
15.6.Market Attractiveness Analysis 
15.6.1. By Indication 
15.6.2. By End User 
15.6.3. By Route of Administration 
15.6.4. By Source of Origin 
15.7. Prominent Trends 

16. MEA Oxytocic Pharmaceuticals Market Analysis and Forecast
16.1.Introduction
16.1.1. Basis Point Share (BPS) Analysis By Country
16.1.2. Y-o-Y Growth Projections By Country
16.2.Market Value Forecast By Indication, 2016–2026
16.2.1. Abortion Induced Incomplete
16.2.2. Inevitable Abortion
16.2.3. Postpartum Hemorrhage
16.2.4. Labor Induction
16.2.5. Labor Arrest
16.3.Market Value Forecast By End User, 2016–2026
16.3.1. Hospitals
16.3.2. Maternity Clinics
16.4.Market Value Forecast By Route of Administration, 2016–2026
16.4.1. Intravenous Infusion/Injection
16.4.2. Intramuscular Injection
16.5.Market Value Forecast By Source of Origin, 2016–2026
16.5.1. Synthetic Oxytocin Derivative
16.5.2. Natural Oxytocin (Animal Pituitary Extract)
16.6.Market Value Forecast By Country, 2016–2026
16.6.1. GCC Countries
16.6.2. South Africa
16.6.3. Rest of MEA
16.7.Market Attractiveness Analysis 
16.7.1. By Indication 
16.7.2. By End User 
16.7.3. By Route of Administration 
16.7.4. By Source of Origin 
16.7.5. By Country
16.8. Prominent Trends 

17. China Oxytocic Pharmaceuticals Market Analysis and Forecast
17.1.Introduction
17.1.1. Basis Point Share (BPS) Analysis By Country
17.1.2. Y-o-Y Growth Projections By Country
17.2.Market Value Forecast By Indication, 2016–2026
17.2.1. Abortion Induced Incomplete
17.2.2. Inevitable Abortion
17.2.3. Postpartum Hemorrhage
17.2.4. Labor Induction
17.2.5. Labor Arrest
17.3.Market Value Forecast By End User, 2016–2026
17.3.1. Hospitals
17.3.2. Maternity Clinics
17.4.Market Value Forecast By Route of Administration, 2016–2026
17.4.1. Intravenous Infusion/Injection
17.4.2. Intramuscular Injection
17.5.Market Value Forecast By Source of Origin, 2016–2026
17.5.1. Synthetic Oxytocin Derivative
17.5.2. Natural Oxytocin (Animal Pituitary Extract)
17.6.Market Attractiveness Analysis 
17.6.1. By Indication 
17.6.2. By End User 
17.6.3. By Route of Administration 
17.6.4. By Source of Origin

Custom Market Research Services

MRRSE offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Get A Free Custom Research Quote